For physicians

Initiate therapy. Sustain it.

Cost-related non-adherence is the leading cause of primary non-fulfilment and early discontinuation among out-of-pocket patients. Rubikcare lets you enrol eligible patients into manufacturer-funded support programs at the point of prescription.

Three steps

Enrol a patient in under 60 seconds.

No paperwork. No calls. No fax. All inside the app, at the point of prescription.

01

Open the program

See every support program available for the therapies you prescribe.

02

Confirm eligibility

A few taps. No paperwork, no phone calls, no faxes.

03

The code goes to your patient

They redeem at any participating pharmacy. You see their refill status — and who needs a follow-up.

Adherence intelligence

Detect non-persistence before it becomes discontinuation.

In chronic therapy, apparent treatment failure is often non-persistence rather than non-response. Rubikcare monitors refill intervals for your enrolled patients and flags a lapsed refill — an early proxy for discontinuation — so you can intervene at the next consultation, or before it.

Objective dispensing data, per patient, in place of self-reported adherence.

↓ 88.2%

Reduced risk of abandoning the first prescription — with cost assistance.

ALK-inhibitor · Peer-reviewed · p<0.001
↓ 24.3%

Reduced risk of discontinuing treatment.

Same cohort · p<0.001
↓ 14%

Reduction in discontinuation — with lower total healthcare cost and fewer hospital visits.

JMCP · Immune-mediated diseases
66%

of studies showed a statistically significant improvement for programme-enrolled patients.

27 of 41 studies · Published review

Published international evidence — establishes the mechanism, not a forecast for any specific brand.

Ready to start?

Download the app, or ask the representative who introduced the programme.

Download the app

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please reload the page.